<DOC>
	<DOCNO>NCT02294370</DOCNO>
	<brief_summary>This study aim improve prediction type 2 diabetes among high-risk individual examine glucose excursion pattern subject impair glucose tolerance . In addition , study show whether currently use diagnostic test could replace easy less expensive method .</brief_summary>
	<brief_title>Variation Glucose Values Early Stages Diabetes - Continuous Glucose Monitoring</brief_title>
	<detailed_description>Type 2 diabetes chronic disease glucose metabolism lead various disable condition . The onset type 2 diabetes gradual shift normal abnormal , give rarely noticeable symptom early stage even later stage damage already cause . Due gradual onset , diagnosis often delay , much half asymptomatic patient remain undetected . The diagnostic criterion diabetes base artificial boundary reflect risk complication relate diabetes . The golden standard diagnosis diabetes 2 hour oral glucose tolerance test , time consume costly . This study aim improve prediction type 2 diabetes among high-risk individual examine glucose excursion pattern subject impair glucose tolerance . In addition , study show whether currently use diagnostic test could replace easy less expensive method .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Individuals impair glucose tolerance ( 2h plasma glucose oral glucose tolerance test &gt; 7.811.1 mmol/l , n=50 ) type 2 diabetes ( fast plasma glucose &gt; 7.0 mmol/l and/or 2h plasma glucose &gt; 11.1 mmol/l two occasion , criterion fulfil oral glucose tolerance test pregnant , n=50 ) short duration ( &lt; 3 year ) ; 40 Padova University Hospital , 60 Botnia Study PPP ( Prevalence , Prediction , Prevention ) Botnia Study Finland . Age 4075 year Medication : insulin , glucagonlike peptide1 ( GLP1 ) analogue , sulphonylureas , oral corticosteroid , thyreostatic agent thyroid hormone , luteinizinghormonereleasing hormone ( LHRH ) analogues Pregnancy Known change retinal fundus photograph Known , microalbuminuria HbA1c &gt; 8 % Fasting plasma glucose &gt; 10 mmol/l Medication metformin , glitazones , gliptins ( acarbose ) allow gliptins acarbose need stop 2 day test study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>continuous glucose monitoring</keyword>
</DOC>